(Q40110867)

reason for preferred rank

17 September 2017

Human leukemic “null” cell line (NALL-1) (English)

1 reference

10.1002/1097-0142(197711)40:5<2131::AID-CNCR2820400523>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197711)40:5%3C2131::AID-CNCR2820400523%3E3.0.CO;2-V

31 December 2022

Human leukemic "null" cell line (NALL-1) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A200333

31 December 2022

0 references

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A200333

31 December 2022

1 reference

10.1002/1097-0142(197711)40:5<2131::AID-CNCR2820400523>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197711)40:5%3C2131::AID-CNCR2820400523%3E3.0.CO;2-V

31 December 2022

author name string

S. Hiraki

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A200333

31 December 2022

I. Miyoshi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A200333

31 December 2022

I. Kubonishi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A200333

31 December 2022

Y. Matsuda

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A200333

31 December 2022

T. Nakayama

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A200333

31 December 2022

H. Kishimoto

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A200333

31 December 2022

H. Masuji

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A200333

31 December 2022

language of work or name

English

0 references

publication date

1 November 1977

1 reference

full work available at URL

17 September 2017

5

1 reference

based on heuristic

inferred from page(s)

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197711)40:5%3C2131::AID-CNCR2820400523%3E3.0.CO;2-V

1 reference

10.1002/1097-0142(197711)40:5<2131::AID-CNCR2820400523>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197711)40:5%3C2131::AID-CNCR2820400523%3E3.0.CO;2-V

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197711)40:5%3C2131::AID-CNCR2820400523%3E3.0.CO;2-V

31 December 2022

1 reference

10.1002/1097-0142(197711)40:5<2131::AID-CNCR2820400523>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197711)40:5%3C2131::AID-CNCR2820400523%3E3.0.CO;2-V

31 December 2022

1 reference

17 September 2017

40

1 reference

17 September 2017

2131-2135

1 reference

17 September 2017

5

1 reference

describes a project that uses

17 September 2017

NALL-1

0 references

cites work

Variation of proliferative activity in leukemic cell populations of patients with acute leukemia

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197711%2940%3A5%3C2131%3A%3AAID-CNCR2820400523%3E3.0.CO%3B2-V

Surface marker characteristics and Epstein-Barr virus studies of two established North American Burkitt's lymphoma cell lines

21 January 2018

4

1 reference

10.1002/1097-0142(197711)40:5<2131::AID-CNCR2820400523>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197711)40:5%3C2131::AID-CNCR2820400523%3E3.0.CO;2-V

The occurrence of the HL-B alloantigens on the cells of unclassified acute lymphoblastic leukemias

31 December 2022

5

1 reference

10.1002/1097-0142(197711)40:5<2131::AID-CNCR2820400523>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197711)40:5%3C2131::AID-CNCR2820400523%3E3.0.CO;2-V

Growth and differentiation in culture of leukemic leukocytes from a patient with acute myelogenous leukemia and re-identification of type-C virus

31 December 2022

6

1 reference

10.1002/1097-0142(197711)40:5<2131::AID-CNCR2820400523>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197711)40:5%3C2131::AID-CNCR2820400523%3E3.0.CO;2-V

Establishment of an Epstein-Barr Virus-Determined Nuclear Antigen-Negative Human B-Cell Line From Acute Lymphoblastic Leukemia: Brief Communication2

31 December 2022

7

1 reference

10.1002/1097-0142(197711)40:5<2131::AID-CNCR2820400523>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197711)40:5%3C2131::AID-CNCR2820400523%3E3.0.CO;2-V

Long-term establishment of a human plasmacyte cell line derived from a patient with IgD multiple myeloma. I. Requirement of a plasmacyte-stimulating factor for the proliferation of myeloma cells in tissue culture

31 December 2022

8

1 reference

10.1002/1097-0142(197711)40:5<2131::AID-CNCR2820400523>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197711)40:5%3C2131::AID-CNCR2820400523%3E3.0.CO;2-V

Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells

31 December 2022

9

1 reference

10.1002/1097-0142(197711)40:5<2131::AID-CNCR2820400523>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197711)40:5%3C2131::AID-CNCR2820400523%3E3.0.CO;2-V

Surface markers on human B and T lymphocytes. II. Presence of Epstein-Barr virus receptors on B lymphocytes

31 December 2022

10

1 reference

10.1002/1097-0142(197711)40:5<2131::AID-CNCR2820400523>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197711)40:5%3C2131::AID-CNCR2820400523%3E3.0.CO;2-V

Trypsin banding of Giemsa-stained chromosomes

31 December 2022

11

1 reference

10.1002/1097-0142(197711)40:5<2131::AID-CNCR2820400523>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197711)40:5%3C2131::AID-CNCR2820400523%3E3.0.CO;2-V

Epstein-barr virus-negative human malignant T-cell lines

31 December 2022

12

1 reference

10.1002/1097-0142(197711)40:5<2131::AID-CNCR2820400523>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197711)40:5%3C2131::AID-CNCR2820400523%3E3.0.CO;2-V

Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas

31 December 2022

13

1 reference

10.1002/1097-0142(197711)40:5<2131::AID-CNCR2820400523>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197711)40:5%3C2131::AID-CNCR2820400523%3E3.0.CO;2-V

An EBV-Genome-Negative Cell Line Established from an American Burkitt Lymphoma; Receptor Characteristics. EBV Infectibility and Permanent Conversion into EBV-Positive Sublines by <i>in vitro</i> Infection

31 December 2022

14

1 reference

10.1002/1097-0142(197711)40:5<2131::AID-CNCR2820400523>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197711)40:5%3C2131::AID-CNCR2820400523%3E3.0.CO;2-V

Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma.

31 December 2022

16

1 reference

10.1002/1097-0142(197711)40:5<2131::AID-CNCR2820400523>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197711)40:5%3C2131::AID-CNCR2820400523%3E3.0.CO;2-V

A Non-T, Non-B Human Leukemia Cell Line (NALM-1): Establishment of the Cell Line and Presence of Leukemia-Associated Antigens2

31 December 2022

19

1 reference

10.1002/1097-0142(197711)40:5<2131::AID-CNCR2820400523>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197711)40:5%3C2131::AID-CNCR2820400523%3E3.0.CO;2-V

Cultured human lymphocytes

31 December 2022

21

1 reference

10.1002/1097-0142(197711)40:5<2131::AID-CNCR2820400523>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197711)40:5%3C2131::AID-CNCR2820400523%3E3.0.CO;2-V

Chromosome preparations of leukocytes cultured from human peripheral blood

31 December 2022

22

1 reference

10.1002/1097-0142(197711)40:5<2131::AID-CNCR2820400523>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197711)40:5%3C2131::AID-CNCR2820400523%3E3.0.CO;2-V

Characteristics of established myeloma and lymphoblastoid cell lines derived from an E myeloma patient: a comparative study.

31 December 2022

23

1 reference

10.1002/1097-0142(197711)40:5<2131::AID-CNCR2820400523>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197711)40:5%3C2131::AID-CNCR2820400523%3E3.0.CO;2-V

Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines

31 December 2022

24

1 reference

10.1002/1097-0142(197711)40:5<2131::AID-CNCR2820400523>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197711)40:5%3C2131::AID-CNCR2820400523%3E3.0.CO;2-V

31 December 2022

Identifiers

10.1002/1097-0142(197711)40:5<2131::AID-CNCR2820400523>3.0.CO;2-V

1 reference

release_cgqmxsa36nhynolvpbr5wwooyi

17 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cgqmxsa36nhynolvpbr5wwooyi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference